FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Approves Abons Generic Clolar

FDA approves an Abon Pharmaceuticals ANDA for clofarabine injection, 20 mg/20 mL, single-use vial, a generic copy of Genzymes Clolar injection.

Medical Devices

Abbott Recalls Certain Lots of Balloon Catheters

Abbott recalls specific lots of three catheters NC Trek RX Coronary Dilatation Catheter, NC Traveler Coronary Dilatation Catheter, and NC Tenku RX PT...

Medical Devices

Oxford Performance Inspection Finds QS Violations

FDAs New England District Office warns Oxford Performance Materials about Quality System violations in its manufacturing of 3D-printed cranial and max...

Medical Devices

QS and MDR Violations Found at Vidco

FDAs Seattle District Office warns Vidco, Inc., about Quality System and Medical Device Reporting Regulation violations in its manufacturing of patien...

Human Drugs

PADE Violations Found at Vertical Pharmaceuticals

FDAs New Jersey District Office warns Vertical Pharmaceuticals about Postmarketing Adverse Drug Experience reporting violations.

Biologics

Fast Track Granted for Sangamo Hemophilia Gene Therapy

FDA grants Sangamo Therapeutics a fast track designation for SB-525, a clinical stage complementary-DNA gene therapy candidate for hemophilia A.

FDA General

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that includes Howard Phillips LLC., International Medsurg Connection, Oxford Performance Materials, V...

Human Drugs

Pharmadax Generic Seroquel XR Approved

FDA approves a Pharmadax ANDA for a generic copy of Seroquel XR (quetiapine fumarate) extended release tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 ...

Company Speaker Programs FCA Focus

Attorney Matthew Curley looks at False Claims Act suits over speaker programs and other potential areas of liability for drug and medical device manuf...

Human Drugs

Senators Concerned About Cures Bill Budget Cuts

Eleven Democratic senators call on the president not to hurt implementation of the 21st Century Cures Act through budget cuts and workforce reductions...